COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months

Table 3 Comparison of the mean FACIT, DASS 21-D, DASS 21-A and DASS-21 S scores between patients with RA who reported worsening and those who did not

	Worse at visit 3 (RA patients)				p value (CI = 95%)	Independent sample effect size*
	No		Yes
	Mean	SD	Mean	SD
FACIT	36.4	9.7	31.5	11.3	0.017	0.47 (0.03 to 0.91)
DASS 21-D	9.5	10.5	12.6	10.9	0.094	-0.29 (-0.73 to 0.144)
DASS 21-A	11.3	10.0	14.4	9.9	0.090	-0.30 (-0.73 to 0.13)
DASS 21-S	13.7	12.4	19.0	9.7	0.023	-0.44 (-0.88 to -0.007)

*Cohen’s d (95% CI): 0.2 to 0.3: Small effect - the difference between the groups is subtle. Approximately 0.5: Medium effect - moderate difference between the groups. 0.8 or more: Large effect - substantial difference between the groups; CI = Confidence interval

ISSN: 2523-3106